+998 (71) 2540022
+998 (71) 2546669
Mon-Fri: 09:00 - 18:00
Sat-Sun: weekend
The list of services
Areas of expertise
How to reach us?
PHARM GROUP focused on acceleration the process of withdrawal the high quality, effective and safe products

PHARM GROUP participated on Indian Pharmexcil's event in Uzbekistan on March 3-4 of 2016
PHARM GROUP had participated on Buyer Seller Meeting and Private meetings with members of Pharmexcil's at its EXPO-CUM-BSM. During the event PHARM GROUP met the following Indian companies

Read more..
Pharmaceutical market of Uzbekistan and the role of the consulting companies in the registration process
Currently, the pharmaceutical market in Uzbekistan is one of the fastest growing among the CIS countries (approximately 8-10% annual growth in 2011-2014, respectively). It depends almost 77% on imported medicines.

Read more..
PROCEDURE OF Registration of Biologically Active ADDITIVES IN Uzbekistan.
As all around the world, over the last few years there has been quite dynamic development of the market of active additives in Uzbekistan.

Read more..
Registration of medical products (MP) in Uzbekistan and the role of consulting companies in it
In 2003, the World Health Organization (WHO) has been developed and published guiding principles of regulation in the field of medical products (VTR №1, 2007 - Regulations for medical products, Review of international practices and guidelines), where the nomenclature has a fundamental role in international harmonization.

Read more..
How to Register Medicines in Uzbekistan
Registration is a key point in the system of finished pharmaceutical products circulation. In all the world countries registration allows to allocate medicine on pharmaceutical market of a certain country.

Read more..
Uzbekistan pharmaceutical market development prospects
Pharmaceutical market of Uzbekistan is a rapidly developing branch in the economics of Uzbekistan. For the last years pharmaceutical market rate growth was about 30%.

Read more..
Advantages of hiring consulting companies for registration (re-registration) of medicines of foreign countries in Uzbekistan
As in other countries, there are companies occupied with consulting on registration or re-registration of medicines, manufactured abroad, in Uzbekistan.

Read more..

Uzbekistan pharmaceutical market development prospects

Ganieva Zilola
Registration Manager
Pharm-Group Uzbekistan
Ph.: +998-71-2457250
zilola@ubi.uz    www.pharm.ubi.uz

Pharmaceutical market of Uzbekistan is a rapidly developing branch in the economics of Uzbekistan. For the last years pharmaceutical market rate growth was about 30%. But still foreign manufacturers dominate on the pharmaceutical market. In Uzbekistan production of such companies as “Berlin Chemie/ Menarine Pharma” (Italy), «Novartis» (Switzerland), “Sanofi-Aventis” (France), etc. is in demand.

The biggest amount of the pharmaceutical market consists of antimicrobial medicines, that is, antibiotics; they are more asked-for not only abroad, but also in Uzbekistan. Formerly all imported medicines in Uzbekistan were subjected to preferential taxation. But in 2011, according to the Decree “On Regulating Import of Finished Medicinal products”, the Cabinet of Ministers of Uzbekistan enacted the list of imported medicines to which Vat benefit is not applied.

Antibiotics of cephalosporin range are also included in this list. VAT benefits are not applied to them. In spite of this the amount of cephalosporin market is growing at the account of domestic manufacturers and import. In 2011 its market in pack reached 56 259 393. It is 74% more than in 2010. Gross share of cephalosporins in 2011 was 11% of the whole market of medicinal products in monetary terms. 

Republic of Uzbekistan

Quantity: 2010


16 960 567

Quantity: 2011


26 701 736

Quantity: 2010 и 2011



Amount inUSD: 2010


15 981 011

Amount inUSD: 2011


33 556 265

Amount inUSD: 2010 и 2011



As we see, the results are quite good.

Now let’s have a look at overall condition of pharmaceutical market of Uzbekistan for 2011/2010 years.

Indexes of2011/2010 years:

Population, million

29,875 million people

GDP, billion $


Average monthly nominal per head income, $

120.2 thousands sums

Inflation, %


Volume of pharmaceutical market, billion $


Dynamics of pharmaceutical market, %, USD


Consume of medicines per head, $


Share of local manufacturers, %


Average price per drug unit, $


Amount of medicines in circulation


Middle level or retail margin, %


National currency

Uzbek sum

Dynamics of pharmaceutical market development in Uzbekistan.

Today the pharmaceutical market of Uzbekistan is one of the rapidly developing among markets of CIS countries. Over the last years the legislative acts, distinctly regulating this field of activity were enacted in the country. In the long view it is supposed to increase the volume of field industry thrice, and production export – in 2.2times.

Uzbekistan pharmaceutical market in the first half of 2011 significantly grew (Fig. 1). And maximal growth is indicated in national currency (+37%).Growth in physical terms was 10% that is a sign of positive tendency after the decline in the first half of 2010, when the purchases went 34% down.

The volume of pharmaceutical market of Uzbekistan  2007-2011 years


The volume of pharmaceutical market, million USD




447 million $




425,6 million $




420 million $




486,1 million $




500 million $

As we see from the table the volume of the pharmaceutical market of Uzbekistan in the recent 5 years reached 500 USD millions. It is forecasted that in 2013 the volume of Uzbekistan pharmaceutical market will reach 680 million dollars. 80% of the pharmaceutical market depends on imported medicinal products; today the imported medicinal products supply 60%-95% percent of Uzbek pharmaceutical market. Generally Uzbekistan imports medicinal products from Ukraine, Russia, India, and Germany. In the following 5 years the import of medicines will increase by 20-22% every year and in 2013 it will reach about 620 million dollars. Generally, Uzbekistan exports the medicines to CIS countries. Year by year the export rate will increase approximately by 20% per year. In 2008 the amount of exported medicinal products from Uzbekistan reached $ 2 million . As analysts suppose, in such growth rates of medicines domestic demand the volume of pharmaceutical market in the following years may reach 1 billion dollars .

In spite of high growth rates of pharmaceutical industry of Uzbekistan the further development of this sector is necessary. Development of medicinal products on the basis of local researches and local raw material is among priority tasks. Uzbekistan’s flora is rich: 138 families, 1023 genera and 4500 species of plant (including 1150 medicinal herbs). That allows producing peculiar medicinal products and biologically active supplements on the basis of local raw materials.

2003-2016 © PHARM GROUP - All rights reserved.